We are delighted to announce that the PROTECT-CH study has been approved for Urgent Public Health (UPH) designation. This is an important milestone for the study, and is crucial to ensuring that we continue to progress at a rapid pace.

What is UPH designation? 

In order to ensure the best use of NHS resources during the COVID-19 pandemic, the National Institute for Health Research established a process by which those delivering COVID-19 studies could apply to be prioritised as UPH research.  

To receive UPH designation, studies are assessed against the below criteria.  

  • How compelling is the science underpinning the proposed study? 
  • Is it feasible to deliver in the current environment of the NHS and social care? 
  • Is the study of appropriate scope and scale for national priority status? 
  • Is the funding appropriate to deliver the proposed outcomes of the study? 
  • Is there an appropriate management plan to avoid interference with recruitment to other UPH studies? 
  • Will results be relevant to this pandemic? 

Once approved as UPH-designated research by the Department of Health and Social Care (DHSC)the set-up and delivery of the study is prioritised by all necessary organisations across the research, health and social care systems.  

More information can be found at the following link: https://www.nihr.ac.uk/covid-19/prioritised-support-for-urgent-covid-19-research.htm